FinscoFinsco

Fulgent Genetics (US.FLGT)

资本配置审计 · 期间： 2014 – 2026

$打开交互终端运行 `audit` 并探索所有维度。→

核心指标

US.FLGT · 同比： 2026 H1 vs 2025 H1

指标数值同比
FCF Conversion154.4%↑
ROE-5.4%↓
Cash Conversion-→
D/E Ratio0.01↓
Gross Margin30.1%↓
US.FLGT (Fulgent Genetics) | YoY: 2026 H1 vs 2025 H1


Metric            Value  YoY
----------------------------
FCF Conversion   154.4%    ↑
ROE               -5.4%    ↓
Cash Conversion       -    →
D/E Ratio          0.01    ↓
Gross Margin      30.1%    ↓
核心指标
US.FLGT (Fulgent Genetics) | YoY: 2026 H1 vs 2025 H1
Metric Value YoY
----------------------------
FCF Conversion 154.4% ↑
ROE -5.4% ↓
Cash Conversion - →
D/E Ratio 0.01 ↓
Gross Margin 30.1% ↓

审计维度

资本流向回报率指标盈利质量负债纪律护城河评估

免费公司

AppleMicrosoftAlphabet-CAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesMicron TechnologySanDiskSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies